Dolan David G, Youk Ada O, Marsh Gary M, Buchanich Jeanine M
Merck & Company, Inc, Whitehouse Station, NJ 08889-0200, USA.
J Occup Environ Med. 2004 Feb;46(2):161-6. doi: 10.1097/01.jom.0000111604.00443.8e.
An historical cohort study was conducted of workers at a pharmaceutical manufacturing plant. The cohort mortality experience of workers ever employed at the plant over the period from 1950 to 1999 was examined. The 1958 workers accumulated 44,294 person-years of experience at the plant, and a total of 384 deaths were identified. Our findings from external comparisons based on standardized mortality ratios (SMRs) in the cohort provide no evidence of excess mortality risk from all causes combined (SMR=0.75), all cancers combined (SMR=0.96), or from certain other individual causes of death. No patterns of excess mortality risk were apparent after stratifying on age and sex or job classification. The mortality experience of this cohort was generally more favorable than that of the general population.
对一家制药厂的工人进行了一项历史性队列研究。研究考察了1950年至1999年期间曾在该厂工作的工人的队列死亡经历。1958名工人在该厂累计有44294人年的工作经历,共确认384例死亡。我们基于队列标准化死亡比(SMR)进行外部比较的结果表明,不存在因所有原因综合导致的超额死亡风险(SMR = 0.75)、所有癌症综合导致的超额死亡风险(SMR = 0.96)或其他某些特定个体死因导致的超额死亡风险。按年龄、性别或工作分类进行分层后,未发现超额死亡风险模式。该队列的死亡经历总体上比一般人群更有利。